Doxorubicin Impurity 6

Synonyma:: (7S,9S)-7-<Doxorubicin Impurity 6;(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy>-9-carboxy-7,8,9,10-tetrahydro-6,9,11-trihydroxy-4-methoxy-5,12-naphthacenedione;(7S,9S)-7-<(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy>-9-carboxy-7,8,9,10-tetrahydro-6,9,11-trihydroxy-4-methoxy-5,12-naphthacenedione;2-Naphthacenecarboxylic acid, 4-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-, (2S,4S)-;(2S,4S)-4-(((4S,5S,6R)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracene-2-carboxylicacid;(2S,4S)-4-(((2R,4S,5S,6S)-4-Amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracene-2-carboxylic acid (Doxorubicin Impurity)

Request For Quotation

Eigenschaften Sicherheit Verwendungswort Produktionsfirma 26

Doxorubicin Impurity 6 Eigenschaften

Global( 26)Lieferanten

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
sgtlifesciences pvt ltd	+8617013299288	dj@sgtlifesciences.com	China	12382	58
China National Standard Pharmaceutical Corporation Limited	+8615391658522	overseasales@yongstandards.com	China	11927	58
Beijing Comparison Pharmaceutical Technology Co., Ltd	010-52878169 15701683040	sales@bjcomparison.com	China	4683	58
ChemStrong Scientific Co.,Ltd	0755-0755-66853366 13670046396	sales@chem-strong.com	China	17982	56
BOC Sciences	16314854226	info@bocsci.com	United States	9926	65
Shenzhen SUNGENING Bio-Medical Co., Ltd.	0755-28967200 13631290199	wxf@sungening.com	China	9506	60
Shanghai Han-Xiang Chemical Co., Ltd.	15971444841	amber@biochempartner.com	China	3063	58
Wuxi Helen Biotechnology Co., Ltd.,	0510-85629785 18013409632	sales@reading-chemicals.com	China	14092	58
Meng Cheng Technology (Shanghai) Co., LTD	400-820-6829	sales@mitachieve.com	China	8864	58
Shandong Wadesen Biotechnology Co. LTD	0531-88723173 18596073690	1047208234@qq.com	China	3447	58

Doxorubicin Impurity 6
(7S,9S)-7-<(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy>-9-carboxy-7,8,9,10-tetrahydro-6,9,11-trihydroxy-4-methoxy-5,12-naphthacenedione
(2S,4S)-4-(((4S,5S,6R)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracene-2-carboxylicacid
2-Naphthacenecarboxylic acid, 4-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-, (2S,4S)-
(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy>
(7S,9S)-7-<
-9-carboxy-7,8,9,10-tetrahydro-6,9,11-trihydroxy-4-methoxy-5,12-naphthacenedione
(2S,4S)-4-(((2R,4S,5S,6S)-4-Amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracene-2-carboxylic acid (Doxorubicin Impurity)
69429-21-6